|
| “Specialty pharmaceuticals represent the fastest growing segment of the prescription drug market in the United States, with a projected 20% annual growth rate. Typically, these products are high cost. It is anticipated that by 2008, the specialty pharmacy component will be >20% of all drug costs, reaching about $73 billion in total dollars. With monthly per patient costs averaging $1000 to $1500, payers (the government, private employers, and managed care organizations) are focusing on ways to effectively manage use of these drugs to realize treatment potential, but at a lowered cost that still ensures patients appropriate access.” National Association of Chain Drug Stores. © 2008 Pharmacy Times |
Investment Criteria
Oceana Therapeutics seeks to partner with leading Healthcare Sector venture capital firms and who offer a successful track record of bringing world-class start ups through the entire market entry, growth and exit lifecycle. If you have a question, e-mail us at ir@oceanathera.com.
OCEANA Corporate Overview
